Literature DB >> 20013194

Enzyme immunoassay of isoprostanes.

Denis M Callewaert1, Charles Sloan.   

Abstract

Isoprostanes are a group of prostaglandin-like compounds that are derived in vivo primarily by free radical-mediated peroxidation of arachidonic acid within phospholipids. The resulting isoprostane moieties are rapidly hydrolyzed, metabolized, and excreted. It is now well recognized that isoprostane levels, most commonly those of 15F(2t)-isoprostane (formerly denoted 8-iso-prostaglandin F(2) (alpha)) in blood or urine, are useful biomarkers for the assessment of oxidative stress, which is a major risk factor for many diseases. Isoprostanes were initially quantified by GC/MS following multiple extraction and purification steps. However, to facilitate routine cost-effective analysis of these biomarkers, immunoassays for isoprostanes were developed. Given the large number of isoprostanes, isoprostane metabolites, and isoprostane conjugates in vivo, the potential for their ex vivo generation from arachidonic acid, and differences among protocols for GC/MS and immunoassay of these biomarkers, it is not surprising that discrepancies arise in values obtained using different methods. When appropriate precautions are taken during sample collection, preparation, and analysis, enzyme immunoassays for 15F(2t)-isoprostane can be used for the reproducible and reliable assessment of oxidative stress in experimental animals or human subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20013194     DOI: 10.1007/978-1-60327-029-8_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

2.  Elevated plasma F2-isoprostane levels in schizophrenia.

Authors:  Ellen E Lee; Lisa T Eyler; Owen M Wolkowitz; Averria Sirkin Martin; Chase Reuter; Helena Kraemer; Dilip V Jeste
Journal:  Schizophr Res       Date:  2016-06-16       Impact factor: 4.939

3.  Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stress.

Authors:  Panagiotis Zis; Patrick McHugh; Andrew McQuillin; Domenico Praticò; Mark Dickinson; Sima Shende; Zuzana Walker; Andre Strydom
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.